News
Johnson & Johnson, tariff and Annual Sales
Digest more
CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.
President Donald Trump suggested Tuesday his administration intends to impose a 200% tariff rate on pharmaceutical imports ...
Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...
President Donald Trump said Tuesday he’s imposing a new 50% tariff on all copper. However, it’s unclear when the new tariff ...
Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...
While the bilateral trade negotiations are in the final stages of discussion between India and the US, the tariffs announced ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
Trump suggested that those levies would not go into effect immediately, saying he will “give people about a year, year and a half” ...
President Trump announced his intent to impose tariffs on imported pharmaceuticals and semiconductors, which may reach 200%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback